echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Autophagy: A new hope for the treatment of neuralgia: joint activation of autophagy and antioxidant response

    Autophagy: A new hope for the treatment of neuralgia: joint activation of autophagy and antioxidant response

    • Last Update: 2021-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Neuropathic pain is one of the most common chronic pain, which is a direct consequence of somatosensory system diseases or diseases.


    More and more evidences show that neuroinflammation and the immune system play an important role in the occurrence and development of neuropathic pain.


    immunity

    In addition, autophagy is an evolutionarily conserved process that plays an important role in the regulation of immune inflammation and nervous system homeostasis.


    Recently, researchers published an article in the Journal of Autophagy that in the maintenance of neuropathic pain, the impairment of autophagy flux mainly occurs in astrocytes .


    Impaired autophagic flux mainly occurs in astrocytes.


    After autophagy inhibition or activation, neuroinflammation and reactive oxygen species (ROS) levels increase or decrease, respectively.


    Impaired autophagy is involved in the process of neuralgia

    Impaired autophagy is involved in the process of neuralgia

    Impairment of autophagy also reduces the protective effect of astrocytes on neurons against ROS stress , because the level of glutathione released by astrocytes decreases, which can be improved by activating the NFE2L2/NRF2 pathway.


    The impairment of autophagy also reduces the protective effect of astrocytes on neurons against ROS stress.


    Therefore, this study provides the basic mechanism by which autophagy participates in the regulation of neuropathic pain .


    The combined activation of autophagy and NFE2L2 may be a new treatment for neuropathic pain The combined activation of autophagy and NFE2L2 may be a new treatment for neuropathic pain

     

    Original source:

    Original source:

    Jian Li et al.


    Jian Li et al.


     

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.